- Home
- ADTX vs ORIS Comparison
ADTX vs ORIS Comparison
Compare ADTX & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- ORIS
- Stock Information
- Founded
- ADTX 2017
- ORIS 2014
- Country
- ADTX United States
- ORIS China
- Employees
- ADTX N/A
- ORIS N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- ORIS Farming/Seeds/Milling
- Sector
- ADTX Health Care
- ORIS Consumer Staples
- Exchange
- ADTX Nasdaq
- ORIS Nasdaq
- Market Cap
- ADTX 4.9M
- ORIS 5.3M
- IPO Year
- ADTX 2020
- ORIS 2024
- Fundamental
- Price
- ADTX $1.01
- ORIS $0.14
- Analyst Decision
- ADTX
- ORIS
- Analyst Count
- ADTX 0
- ORIS 0
- Target Price
- ADTX N/A
- ORIS N/A
- AVG Volume (30 Days)
- ADTX 172.4K
- ORIS 17.4M
- Earning Date
- ADTX 11-17-2025
- ORIS 01-01-0001
- Dividend Yield
- ADTX N/A
- ORIS N/A
- EPS Growth
- ADTX N/A
- ORIS N/A
- EPS
- ADTX N/A
- ORIS 0.17
- Revenue
- ADTX $12,051.00
- ORIS $15,014,000.00
- Revenue This Year
- ADTX $15,768.94
- ORIS N/A
- Revenue Next Year
- ADTX N/A
- ORIS N/A
- P/E Ratio
- ADTX N/A
- ORIS $0.83
- Revenue Growth
- ADTX N/A
- ORIS N/A
- 52 Week Low
- ADTX $0.81
- ORIS $0.08
- 52 Week High
- ADTX $4,698.00
- ORIS $56.01
- Technical
- Relative Strength Index (RSI)
- ADTX 47.27
- ORIS 46.56
- Support Level
- ADTX $0.98
- ORIS $0.11
- Resistance Level
- ADTX $1.11
- ORIS $0.20
- Average True Range (ATR)
- ADTX 0.07
- ORIS 0.02
- MACD
- ADTX 0.01
- ORIS 0.01
- Stochastic Oscillator
- ADTX 54.34
- ORIS 34.85
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).